Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion type Assertion NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_head.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion description "[Hepatocyte growth factor (HGF) activator inhibitor type 1 (HAI-1) and type 2 (HAI-2) are new Kunitz-type serine protease inhibitors that were recently purified and cloned from the human stomach cancer cell line MKN45 as specific inhibitors against HGF activator.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_provenance.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion evidence source_evidence_literature NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_provenance.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion SIO_000772 10762618 NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_provenance.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion wasDerivedFrom befree-2016 NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_provenance.
- NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_assertion wasGeneratedBy ECO_0000203 NP280930.RASZfYEIo-lNRNz2ncjC7Zy6-4jb7LWI9vBM6br3frx3c130_provenance.